Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TBRA | AMGN | BMY | GILD | VRTX |
| Company | Tobira Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 41.83 | 262.48 | 57.41 | 93.00 | 401.53 |
| High | 42.33 | 264.55 | 57.77 | 94.05 | 410.68 |
| Low | 40.39 | 261.36 | 57.01 | 92.10 | 401.27 |
| Last | 42.09 | 264.49 | 57.76 | 93.95 | 408.18 |
| Change | +0.27 | +0.49 | +0.18 | +0.55 | +2.91 |
| % Change | +0.65% | +0.19% | +0.31% | +0.59% | +0.72% |
| Volume | 521,800 | 1,520,500 | 3,668,100 | 2,109,100 | 1,468,500 |
| 20-Day Average Volume | 230,795 | 5,000,690 | 11,391,425 | 7,173,320 | 1,832,675 |
| Previous Close | 41.82 | 264.00 | 57.58 | 93.40 | 405.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 40.68 | 272.02 | 57.87 | 92.30 | 452.00 |
| 20-Day Raw Stochastic | 91.81% | 36.88% | 53.88% | 87.27% | 30.76% |
| 20-Day Relative Strength | 87.55% | 33.45% | 54.00% | 58.19% | 33.99% |
| Weighted Alpha | +35.00 | -14.60 | +20.51 | +26.09 | -7.89 |
| Today's Opinion | N/A | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | N/A | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | N/A | 40% Sell | 100% Buy | 80% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.42% since 10/24/16 | -0.55% since 12/17/24 | +0.19% since 12/17/24 | +1.24% since 12/17/24 | -13.01% since 12/17/24 |
| Low | 40.39 on 10/31/16 | 253.30 on 12/19/24 | 56.08 on 12/20/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 42.33 on 10/31/16 | 269.61 on 12/20/24 | 58.54 on 12/18/24 | 94.05 on 12/24/24 | 471.05 on 12/18/24 |
| 1-Month | |||||
| %Chg | +5.91% since 09/30/16 | -10.20% since 11/22/24 | -1.89% since 11/22/24 | +4.17% since 11/22/24 | -9.49% since 11/22/24 |
| Low | 39.40 on 10/04/16 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 42.33 on 10/31/16 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +876.57% since 07/29/16 | -20.07% since 09/24/24 | +13.39% since 09/24/24 | +12.13% since 09/24/24 | -11.84% since 09/24/24 |
| Low | 3.76 on 08/02/16 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 42.33 on 10/31/16 | 329.50 on 09/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +434.82% since 04/29/16 | -16.87% since 06/24/24 | +36.77% since 06/24/24 | +32.83% since 06/24/24 | -14.06% since 06/24/24 |
| Low | 3.76 on 08/02/16 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 42.33 on 10/31/16 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 787,090 | 142,172,096 | 117,147,504 | 117,086,688 | 105,118,176 |
| Shares Outstanding, K | 18,820 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -49,620,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 1,060,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -13,340,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | -2.81 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/08/16 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 49.21 | 21.08 | 0.00 |